NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 43 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $571,000 | +84.2% | 70,204 | +4.1% | 0.01% | +66.7% |
| Q2 2016 | $310,000 | +12.7% | 67,408 | +2.1% | 0.00% | 0.0% |
| Q1 2016 | $275,000 | -29.8% | 66,039 | +30.3% | 0.00% | -25.0% |
| Q4 2015 | $392,000 | -38.4% | 50,674 | +3.4% | 0.00% | -42.9% |
| Q3 2015 | $636,000 | -16.1% | 49,008 | -2.0% | 0.01% | +75.0% |
| Q2 2015 | $758,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|